State legislators across the country are addressing healthcare costs as a top priority during this legislative session. While making healthcare more affordable is a worthy goal, several bills that have been introduced claiming to lower healthcare costs would instead increase costs, reduce access to prescription drugs, and cause the loss of thousands of jobs. Since […]
A new report challenges assertions made during the committee’s recent hearing on the role of pharmacy benefit managers.
The FTC fails to acknowledge the benefits of pharmacy benefit managers and wrong blames them for high drug prices.
PBMs lower healthcare costs and another government agency overspent because a PBM was not used.
SB 1550 will negatively impact Florida’s private sector healthcare market and ultimately harm patients.
A Bill introduced in the Senate takes aim at PBMS and private sector healthcare.
Long overdue oversight hearings were finally held in the House of Representatives.
In 2022, CCAGW helped protect taxpayers with wins on data privacy, broadband spending, drug price controls, and reducing red tape.
Increasing regulations on pharmacy benefit managers will not reduce the cost of pharmaceuticals.
President Biden’s support of intellectual property waivers threatens development of future life-saving medicines.
